Himalaya to hire 1,000 people, eyes Rs 2,500cr revenue in FY18

CEO Philipe Haydon said the company is aiming to expand presence in all the verticals it is in

Himalaya to hire 1,000 people, eyes Rs 2,500cr revenue in FY18
Press Trust of India Bengaluru
Last Updated : Sep 25 2016 | 12:21 PM IST
Maintaining over 20 per cent CAGR, wellness firm Himalaya Drug Company is looking at Rs 2,500 crore revenue next fiscal and plans to hire around 1,000 people as it enters new verticals and expands distribution network.

The homegrown firm had posted Rs 1,800 crore turnover last fiscal and is expecting Rs 2,100 crore sales in 2016-17.

"We are expecting revenues of up to Rs 2,500 crore in the next fiscal FY18 maintaining a compounded annual growth rate (CAGR) of over 20 per cent year-on-year," Himalaya Drug Company CEO Philipe Haydon told PTI.

Also Read

At present, Himalaya's biggest vertical is personal care contributing 42 per cent to total sales, followed by pharmaceutical 32 per cent, baby care 15 per cent, animal health 5 per cent and wellness 5 per cent, he added.

"We have just launched mothercare products with the launch of 4 products followed by at least 8 products in next one and one and half years. We expect this segment to contribute to 5 to 6 per cent to our revenues in next two years," Haydon said.

The company is aiming to expand presence in all the verticals it is in, he added.

As part of the expansion process the company is also looking to add to its workforce which is around 9,000 to 10,000 at present.

"We plan to add at least a 1,000 people during the next fiscal in all the verticals as we increase our verticals and distribution network that we are in," Haydon said.

The company, which sells herbal products, is also enhancing its research in order to tap into the knowledge of ancient Indian medicinal practice and has developed a large research and development facility.

"Our strong focus on innovation and rigorous research has helped us develop more than 300 products spanning 7 divisions and we will continue to explore the potential of Ayurveda in improving the quality of life," Himalaya Drug Company Chief Scientific Officer Rangesh Paramesh said.

Himalaya has spent years studying the therapeutic benefits of herbs to use in its products and every product is created following stringent standards of safety, efficacy and quality control, he added.

It has a range of over 300 healthcare and personal care products including popular brands like Liv 52, Cystone, and Bonnisan. The company currently operates in over 90 countries.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 25 2016 | 11:48 AM IST

Next Story